Thank you for sharing!

Your article was successfully shared with the contacts you provided.
WASHINGTON — If a firm is looking to expand its food and drug practice, it can hardly do better than snagging the chief counsel of the U.S. Food & Drug Administration, which is exactly what Hunton & Williams has done. Sheldon Bradshaw, the FDA’s chief counsel, will join the firm’s Washington office as a partner and co-chair of its food and drug practice in October. “We have been looking to expand our Food and Drug Practice and Sheldon is an exceptional addition to our existing team,” said Wally Martinez, managing partner of Hunton & Williams. “He brings a wealth of experience from both the FDA and the Department of Justice which will be invaluable to our clients not only served by the Food and Drug Practice, but many of our other practices, as well.” Bradshaw joins the recent exodus of high-ranking Bush administration officials as that administration approaches its final year. He served as chief counsel of the FDA since 2005, where he was responsible for providing legal advice to senior leadership at the FDA and the Department of Health and Human Services and for managing the work of more than 100 lawyers and staff. During his tenure, he oversaw controversial regulatory issues dealing with drugs, biologics, medical devices, food, and other products. He also reviewed and approved every regulation, guidance and warning letter issued by the FDA and oversaw all agency litigation. He joined the government in 2001 after practicing as an associate with Howrey Simon Arnold & White. He was appointed deputy assistant attorney general for the Office of Legal Counsel at the U.S. Department of Justice. Before moving to the FDA, Bradshaw served as the principal deputy assistant attorney general in the Justice Department’s Civil Rights Division.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]

Reprints & Licensing
Mentioned in a Law.com story?

License our industry-leading legal content to extend your thought leadership and build your brand.


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.